| Literature DB >> 33260666 |
Thilina U Jayawardena1, K K Asanka Sanjeewa1, D P Nagahawatta1, Hyo-Geun Lee1, Yu-An Lu1, A P J P Vaas2, D T U Abeytunga2, C M Nanayakkara3, Dae-Sung Lee4, You-Jin Jeon1,5.
Abstract
This study involves enzymatic extraction of fucoidan from Sargassum swartzii and further purification via ion-exchange chromatography. The chemical and molecular characteristics of isolated fucoidan is evaluated concerning its anti-inflammatory potential in RAW 264.7 macrophages under LPS induced conditions. Structural properties of fucoidan were assessed via FTIR and NMR spectroscopy. NO production stimulated by LPS was significantly declined by fucoidan. This was witnessed to be achieved via fucoidan acting on mediators such as iNOS and COX-2 including pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β), with dose dependent down-regulation. Further, the effect is exhibited by the suppression of TLR mediated MyD88, IKK complex, ultimately hindering NF-κB and MAPK activation, proposing its therapeutic applications in inflammation related disorders. The research findings provide an insight in relation to the sustainable utilization of fucoidan from marine brown algae S. swartzii as a potent anti-inflammatory agent in the nutritional, pharmaceutical, and cosmeceutical sectors.Entities:
Keywords: MAPK; NF-κB; Sargassum swartzii; TLR/MyD88; fucoidan
Mesh:
Substances:
Year: 2020 PMID: 33260666 PMCID: PMC7760840 DOI: 10.3390/md18120601
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118